Docebo Inc. DCBO
| Analyste |
Entreprise |
Prix lors de l'analyse |
Prix cible |
Gain potentiel |
Date de publication |
| Ken Wong |
Oppenheimer |
24.61 $ |
35 $ |
10.39 % |
05/11/2025 |
| Josh Baer |
Morgan Stanley |
29.16 $ |
41 $ |
11.84 % |
16/04/2025 |
| Kevin Krishnaratne |
Scotiabank |
45.46 $ |
55 $ |
9.54 % |
24/10/2024 |
| Kevin Kumar |
Goldman Sachs |
42.47 $ |
48 $ |
5.53 % |
16/09/2024 |
| Ryan MacDonald |
Needham |
42.06 $ |
50 $ |
7.94 % |
12/09/2024 |
| Robert Young |
Canaccord Genuity |
41.74 $ |
54 $ |
12.26 % |
09/08/2024 |
| George Sutton |
Craig-Hallum |
37.22 $ |
58 $ |
20.78 % |
07/06/2024 |
| Robert Young |
Canaccord Genuity |
36.26 $ |
55 $ |
18.74 % |
14/05/2024 |
| Kevin Krishnaratne |
Scotiabank |
36.26 $ |
50 $ |
13.74 % |
14/05/2024 |
| Ryan MacDonald |
Needham |
51.22 $ |
56 $ |
4.78 % |
14/11/2023 |
| Josh Baer |
Morgan Stanley |
40.81 $ |
49 $ |
8.19 % |
18/08/2023 |
| Brett Knoblauch |
Cantor Fitzgerald |
71.87 $ |
82 $ |
10.13 % |
13/08/2021 |